Serum level of galectin-9 as a potential biomarker for high risk of malignancy in dermatomyositis.
Sign Up to like & getrecommendations! Published in 2023 at "Rheumatology"
DOI: 10.1093/rheumatology/kead222
Abstract: OBJECTIVES Galectin-9, as immune checkpoint protein, plays a role in regulating autoimmunity and tumour immunity. Therefore, we explored the pathophysiological link between galectin-9 and malignancy in cancer-related DM (CRDM). METHODS Serum galectin-9 were quantified via… read more here.
Keywords: crdm; serum galectin; malignancy; galectin ... See more keywords